share_log

華康生物醫學:有關收購目標公司19%股權及提供貸款之須予披露交易之第二份補充公告

Huakang Biomedical Holdings: SECOND SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF 19% EQUITY INTEREST OF THE TARGET COMPANY AND PROVISION OF LOAN

HKEX ·  Feb 9, 2023 19:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more